Xeljanz Европейский союз - норвежский - EMA (European Medicines Agency)

xeljanz

pfizer europe ma eeig - tofacitinib - leddgikt, reumatoid - immunsuppressive - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 og 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Alpha Max 10 mg/ ml Норвегия - норвежский - Statens legemiddelverk

alpha max 10 mg/ ml

pharmaq as - deltametrin - konsentrat til behandlingsoppløsning til fisk - 10 mg/ ml

Baycox Sheep vet 50 mg/ ml Норвегия - норвежский - Statens legemiddelverk

baycox sheep vet 50 mg/ ml

bayer animal health gmbh - toltrazuril - mikstur, suspensjon - 50 mg/ ml

Dolorex vet 10 mg/ ml Норвегия - норвежский - Statens legemiddelverk

dolorex vet 10 mg/ ml

intervet international b.v. - butorfanoltartrat - injeksjonsvæske, oppløsning - 10 mg/ ml

Falakef 1000 mg Норвегия - норвежский - Statens legemiddelverk

falakef 1000 mg

i.c.f. srl industria chimica fine - cefaleksinmonohydrat - tablett, filmdrasjert - 1000 mg

Falakef 500 mg Норвегия - норвежский - Statens legemiddelverk

falakef 500 mg

i.c.f. srl industria chimica fine - cefaleksinmonohydrat - tablett, filmdrasjert - 500 mg

Immunine 1200 IE Норвегия - норвежский - Statens legemiddelverk

immunine 1200 ie

baxalta innovations gmbh - koagulasjonsfaktor ix, human - pulver og væske til injeksjons-/infusjonsvæske, oppløsning - 1200 ie

Immunine 600 IE Норвегия - норвежский - Statens legemiddelverk

immunine 600 ie

baxalta innovations gmbh - koagulasjonsfaktor ix, human - pulver og væske til injeksjons-/infusjonsvæske, oppløsning - 600 ie

Marcain Spinal 5 mg/ ml Норвегия - норвежский - Statens legemiddelverk

marcain spinal 5 mg/ ml

aspen pharma trading limited - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml

Marcain Spinal Tung 5 mg/ ml Норвегия - норвежский - Statens legemiddelverk

marcain spinal tung 5 mg/ ml

aspen pharma trading limited - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml